Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Esserman

Showing results (31-40 of 308) with videos related to

Pageof 31
Sort By:
JAMA|January 9, 2014
Changing the terminology of cancer--replyLaura J Esserman, Ian M Thompson, Brian J Reid
Journal of Women'S Health (2002)|July 18, 2022
Why It Is Time to Challenge Entrenched Beliefs About Breast Cancer ScreeningLaura J Esserman, Barbara A Parker, Andrea Z LaCroix
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer CareRita A Mukhtar, Jasmine M Wong, Laura J Esserman
Archives of Internal Medicine|May 24, 2006
Clinical trials are required to prove the chemopreventive worth of statinsAnjali S Kumar, Christopher C Benz, Laura J Esserman
Journal of the National Cancer Institute|January 28, 2024
RE: Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast densityOlasubomi J Omoleye, Laura J Esserman, Olufunmilayo I Olopade
The Lancet. Oncology|March 3, 2022
Survivorship after neoadjuvant chemotherapy - Authors' replyChristina Yau, Marie Osdoit, Laura J Esserman, et al.
Annals of Internal Medicine|March 25, 2014
Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelinesCristina O'Donoghue, Martin Eklund, Elissa M Ozanne, et al.
BMC Medical Informatics and Decision Making|January 16, 2014
Development of a personalized decision aid for breast cancer risk reduction and managementElissa M Ozanne, Rebecca Howe, Zehra Omer, et al.
BMC Global and Public Health|July 4, 2025
Translating risk-based breast cancer screening to limited-resource settingsKimberly Badal, Akash Maniam, Sarafina Urenna Otis, et al.
Nature Reviews. Clinical Oncology|August 15, 2012
Breast cancer screening: the questions answeredPhilippe Autier, Laura J Esserman, Chris I Flowers, et al.
Pageof 31

Showing results (31-40 of 308) with videos related to

Sort By:
Pageof 31
JAMA|January 9, 2014
Changing the terminology of cancer--replyLaura J Esserman, Ian M Thompson, Brian J Reid
Journal of Women'S Health (2002)|July 18, 2022
Why It Is Time to Challenge Entrenched Beliefs About Breast Cancer ScreeningLaura J Esserman, Barbara A Parker, Andrea Z LaCroix
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer CareRita A Mukhtar, Jasmine M Wong, Laura J Esserman
Archives of Internal Medicine|May 24, 2006
Clinical trials are required to prove the chemopreventive worth of statinsAnjali S Kumar, Christopher C Benz, Laura J Esserman
Journal of the National Cancer Institute|January 28, 2024
RE: Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast densityOlasubomi J Omoleye, Laura J Esserman, Olufunmilayo I Olopade
The Lancet. Oncology|March 3, 2022
Survivorship after neoadjuvant chemotherapy - Authors' replyChristina Yau, Marie Osdoit, Laura J Esserman, et al.
Annals of Internal Medicine|March 25, 2014
Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelinesCristina O'Donoghue, Martin Eklund, Elissa M Ozanne, et al.
BMC Medical Informatics and Decision Making|January 16, 2014
Development of a personalized decision aid for breast cancer risk reduction and managementElissa M Ozanne, Rebecca Howe, Zehra Omer, et al.
BMC Global and Public Health|July 4, 2025
Translating risk-based breast cancer screening to limited-resource settingsKimberly Badal, Akash Maniam, Sarafina Urenna Otis, et al.
Nature Reviews. Clinical Oncology|August 15, 2012
Breast cancer screening: the questions answeredPhilippe Autier, Laura J Esserman, Chris I Flowers, et al.
Pageof 31